» Articles » PMID: 35478701

Inhibitory Control of Saccadic Eye Movements and Cognitive Impairment in Mild Cognitive Impairment

Overview
Specialty Geriatrics
Date 2022 Apr 28
PMID 35478701
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mild cognitive impairment (MCI) may occur due to several forms of neurodegenerative diseases and non-degenerative conditions and is associated with cognitive impairment that does not affect everyday activities. For a timely diagnosis of MCI to prevent progression to dementia, a screening tool of fast, low-cost and easy access is needed. Recent research on eye movement hints it a potential application for the MCI screening. However, the precise extent of cognitive function decline and eye-movement control alterations in patients with MCI is still unclear.

Objective: This study examined executive control deficits and saccade behavioral changes in patients with MCI using comprehensive neuropsychological assessment and interleaved saccade paradigms.

Methods: Patients with MCI ( = 79) and age-matched cognitively healthy controls (HC) ( = 170) completed four saccadic eye-movement paradigms: prosaccade (PS)/antisaccade (AS), Go/No-go, and a battery of neuropsychological tests.

Results: The findings revealed significantly longer latency in patients with MCI than in HC during the PS task. Additionally, patients with MCI had a lower proportion of correct responses and a marked increase in inhibition errors for both PS/AS and Go/No-go tasks. Furthermore, when patients with MCI made errors, they failed to self-correct many of these inhibition errors. In addition to the increase in inhibition errors and uncorrected inhibition errors, patients with MCI demonstrated a trend toward increased correction latencies. We also showed a relationship between neuropsychological scores and correct and error saccade responses.

Conclusion: Our results demonstrate that, similar to patients with Alzheimer's dementia (AD), patients with MCI generate a high proportion of erroneous saccades toward the prepotent target and fail to self-correct many of these errors, which is consistent with an impairment of inhibitory control and error monitoring.

Significance: The interleaved PS/AS and Go/No-go paradigms are sensitive and objective at detecting subtle cognitive deficits and saccade changes in MCI, indicating that these saccadic eye movement paradigms have clinical potential as a screening tool for MCI.

Citing Articles

Abnormal eye movements: relationship with clinical symptoms and predictive value for Alzheimer's disease.

Qi J, Lian T, Guo P, He M, Li J, Li J Front Aging Neurosci. 2024; 16:1471698.

PMID: 39640423 PMC: 11617582. DOI: 10.3389/fnagi.2024.1471698.


Task-evoked pupillary responses as potential biomarkers of mild cognitive impairment.

Opwonya J, Kim K, Lee K, Kim J, Kim J Alzheimers Dement (Amst). 2024; 16(4):e70019.

PMID: 39391021 PMC: 11465026. DOI: 10.1002/dad2.70019.


Research Progress of Eye Movement Analyses and its Detection Algorithms in Alzheimer's Disease.

He X, Selesnick I, Zhu M Curr Alzheimer Res. 2024; 21(2):91-100.

PMID: 38661033 DOI: 10.2174/0115672050300564240416074025.


Prefrontal intra-individual ERP variability and its asymmetry: exploring its biomarker potential in mild cognitive impairment.

Eyamu J, Kim W, Kim K, Lee K, Kim J Alzheimers Res Ther. 2024; 16(1):83.

PMID: 38615028 PMC: 11015694. DOI: 10.1186/s13195-024-01452-5.


Prefrontal event-related potential markers in association with mild cognitive impairment.

Eyamu J, Kim W, Kim K, Lee K, Kim J Front Aging Neurosci. 2023; 15:1273008.

PMID: 37927335 PMC: 10620700. DOI: 10.3389/fnagi.2023.1273008.


References
1.
Gauthier S, Reisberg B, Zaudig M, Petersen R, Ritchie K, Broich K . Mild cognitive impairment. Lancet. 2006; 367(9518):1262-70. DOI: 10.1016/S0140-6736(06)68542-5. View

2.
Jamadar S, Fielding J, Egan G . Quantitative meta-analysis of fMRI and PET studies reveals consistent activation in fronto-striatal-parietal regions and cerebellum during antisaccades and prosaccades. Front Psychol. 2013; 4:749. PMC: 3797465. DOI: 10.3389/fpsyg.2013.00749. View

3.
Crawford T, Higham S, Renvoize T, Patel J, Dale M, Suriya A . Inhibitory control of saccadic eye movements and cognitive impairment in Alzheimer's disease. Biol Psychiatry. 2005; 57(9):1052-60. DOI: 10.1016/j.biopsych.2005.01.017. View

4.
Braak H, Braak E . Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging. 1995; 16(3):271-8; discussion 278-84. DOI: 10.1016/0197-4580(95)00021-6. View

5.
Peltsch A, Hemraj A, Garcia A, Munoz D . Saccade deficits in amnestic mild cognitive impairment resemble mild Alzheimer's disease. Eur J Neurosci. 2014; 39(11):2000-13. DOI: 10.1111/ejn.12617. View